Yorke Justin W. - 27 Jun 2023 Form 4 Insider Report for Processa Pharmaceuticals, Inc. (PCSA)

Role: Director
Signature: /s/ Justin W. Yorke by Michael B. Kirwan, as Attorney-in-Fact
Issuer symbol: PCSA
Transactions as of: 27 Jun 2023
Net transactions value: $0
Form type: 4
Filing time: 24 Jul 2023, 18:35:50 UTC
Previous filing: 15 May 2023
Next filing: 10 Oct 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PCSA	Common Stock	Options Exercise		+23,636	+71%		56,729	27 Jun 2023	Direct	F1
holding	PCSA	Common Stock						519,890	27 Jun 2023	By Richland Fund, LLC

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PCSA	Restricted Stock	Options Exercise	$0	-23,636	-100%	$0.000000^*	0	27 Jun 2023	Common Stock	23,636	$0.000000	Direct	F1
transaction	PCSA	Restricted Stock	Award	$0	+101,365		$0.000000	101,365	27 Jun 2023	Common Stock	101,365	$0.000000	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Vesting of time-based restricted shares.
F2	The restricted stock vests on the earliest of one year from date of grant or the next annual meeting of stockholders.